← back to search

Xiaoping Chen

Central South University · CN
Area of research
Cardiology and Cardiovascular Medicine · Molecular Biology
Research interest
Research interests include Antiplatelet Therapy and Cardiovascular Diseases, Epigenetics and DNA Methylation, Cancer-related molecular mechanisms research, and Pharmacogenetics and Drug Metabolism.
h-index
39
citations
6,181
works
275
NIH funding
primary concept
Medicine
email

Recent publications

Prednisone exposure in utero enhances LXRα-SREBP1 signaling and MAFLD risk in male offspring on high-fat diet.
2026cited by 0position: contributordoi
Gut microbiota influence pharmacokinetics variability in aging mice: Effects vary from drug to drug.
2026cited by 0position: contributordoi
Targeting Aurora kinase B regulates cholesterol metabolism and enhances chemoimmunotherapy in cholangiocarcinoma
Gut 2025cited by 8position: middledoi
Dual one-step recombinase-aided PCR for rapid detection of Candida in blood
Applied Microbiology and Biotechnology 2025cited by 4position: middledoi
Regulation of lipoprotein processing by GPNMB in foamy macrophages: potential therapeutic targets for atherosclerosis.
2025cited by 1position: contributordoi
Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapy
Cancer Cell 2024cited by 65position: middledoi
Gentulizumab, a novel anti-CD47 antibody with potent antitumor activity and demonstrates a favorable safety profile.
2024cited by 7position: contributordoi
NDC80/HEC1 promotes macrophage polarization and predicts glioma prognosis via single-cell RNA-seq and in vitro experiment.
2024cited by 4position: contributordoi
Effects of immunorelated gene polymorphisms on trastuzumab targeting breast cancer cell <i>in vitro</i>.
2024cited by 1position: contributordoi
Establishment of the visualization platform for ADR query and analysis: an example of severe skin adverse reactions caused by sulfonylureas (Preprint)
2024cited by 0position: contributordoi
Astaxanthin promotes mitochondrial biogenesis and antioxidant capacity in chronic high-intensity interval training
European Journal of Nutrition 2023cited by 36position: middledoi
scRNA-seq Reveals the Mechanism of Fatty Acid Desaturase 2 Mutation to Repress Leaf Growth in Peanut (Arachis hypogaea L.)
Cells 2023cited by 14position: middledoi
<i>CD80</i> DNA methylation and single-nucleotide polymorphism associated with clopidogrel response: a whole-genome DNA methylation analysis in acute coronary syndrome.
2023cited by 0position: contributordoi
Comprehensive Metabolic Profiling of Inflammation Indicated Key Roles of Glycerophospholipid and Arginine Metabolism in Coronary Artery Disease
Frontiers in Immunology 2022cited by 99position: middledoi
Plasma metabolomics provides new insights into the relationship between metabolites and outcomes and left ventricular remodeling of coronary artery disease
Cell & Bioscience 2022cited by 27position: middledoi
Establishment of the visualization platform for ADR query and analysis: an example of severe skin adverse reactions caused by sulfonylureas (Preprint)
2022cited by 0position: contributordoi
Comprehensive Metabolomics Identified the Prominent Role of Glycerophospholipid Metabolism in Coronary Artery Disease Progression
Frontiers in Molecular Biosciences 2021cited by 42position: middledoi
Influence of <i>GAS5</i>/MicroRNA-223-3p/P2Y12 Axis on Clopidogrel Response in Coronary Artery Disease.
2021cited by 18position: contributordoi
Effect of Physician-Pharmacist Participation in the Management of Ambulatory Cancer Pain Through a Digital Health Platform: Randomized Controlled Trial.
2021cited by 14position: contributordoi
Association of FMO3 rs1736557 polymorphism with clopidogrel response in Chinese patients with coronary artery disease.
2021cited by 7position: contributordoi
Fas-Associated Factor 1 Promotes Hepatic Insulin Resistance via JNK Signaling Pathway.
2021cited by 3position: contributordoi
Correction: Effect of Physician-Pharmacist Participation in the Management of Ambulatory Cancer Pain Through a Digital Health Platform: Randomized Controlled Trial.
2021cited by 0position: contributordoi
Correction: Effect of Physician-Pharmacist Participation in the Management of Ambulatory Cancer Pain Through a Digital Health Platform: Randomized Controlled Trial (Preprint)
2021cited by 0position: contributordoi
Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019-nCoV Infection.
2020cited by 244position: contributordoi
Aberrant ASPM expression mediated by transcriptional regulation of FoxM1 promotes the progression of gliomas.
2020cited by 23position: contributordoi
Perception of the association between erectile dysfunction and cardiovascular disease among Chinese physicians: an online survey.
2020cited by 3position: contributordoi
Effect of Physician-Pharmacist Participation in the Management of Ambulatory Cancer Pain Through a Digital Health Platform: Randomized Controlled Trial (Preprint)
2020cited by 0position: contributordoi
Knockdown ATG4C inhibits gliomas progression and promotes temozolomide chemosensitivity by suppressing autophagic flux.
2019cited by 47position: contributordoi
High-Dose Astaxanthin Supplementation Suppresses Antioxidant Enzyme Activity during Moderate-Intensity Swimming Training in Mice
Nutrients 2019cited by 35position: middledoi
HBsAg Loss with Peg-interferon Alfa-2a in Hepatitis B Patients with Partial Response to Nucleos(t)ide Analog: New Switch Study
Journal of Clinical and Translational Hepatology 2018cited by 161position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 17 papers (2020–2026)Jian Xiao · Elsevier, Inc.6 papers (2020–2024)Yao Chen · Department of Clinical Pharmacology5 papers (2020–2022)Lu Zhang · Central South University5 papers (2020–2022) · 4 papers (2020–2021)Fang-Zhou Liu · 4 papers (2020–2021)Shu-Sen Sun · Western New England University4 papers (2020–2021)Ya-Min Huang · Dongguan University of Technology4 papers (2020–2021)Howard L. McLeod · University of North Carolina at Chapel Hill4 papers (2020–2021)Ke-Ke Liu · Jinan University4 papers (2020–2021)Hang-Xing Huang · Central South University4 papers (2020–2021)Shilong Zhong · Guangdong University of Technology3 papers (2021–2022)Qilin Ma · Jiangsu University2 papers (2021–2022)Hui Chen · Guangzhou University of Chinese Medicine2 papers (2021–2022)Weihua Lai · Nanchang University2 papers (2021–2022)Hanping Li · Southern Medical University2 papers (2021–2022)Quan Cheng · Clarivate PLC2 papers (2020–2024)Julien S. Baker · Ningbo University2 papers (2019–2023) · 2 papers (2019–2023)Zixian Wang · Shanghai Medical College of Fudan University2 papers (2021–2022)